改良德尔菲法对成人重症患者167种药物肾毒性潜力达成共识
该研究采用三轮、国际、跨学科、基于网络的改良德尔菲法,由24名来自重症医学、肾脏病学和药学领域的国际经验丰富临床医生对成人重症患者使用的167种药物进行肾毒性潜力评估。药物肾毒性潜力按标准使用情况评分:0=无肾毒性潜力,1=可能肾毒性潜力,2=很可能肾毒性潜力,3=确定肾毒性潜力。共识结果显示20种药物被评为肾毒性很可能或很可能/确定。肾毒性潜力指数评级有助于机构肾毒性药物管理项目优先针对肾毒性潜力较高的药物,并为研究和按严重程度详细评估每种药物提供同质性。
要点
- 24名国际重症、肾脏病和药学专家通过三轮改良德尔菲法对167种成人重症用药进行肾毒性潜力评级。
- 肾毒性潜力指数评分标准:0=无肾毒性潜力,1=可能肾毒性潜力,2=很可能肾毒性潜力,3=确定肾毒性潜力。
- 共识结果显示20种药物被评为肾毒性很可能或很可能/确定。
- 肾毒性潜力指数评级可帮助机构肾毒性药物管理项目优先针对肾毒性潜力较高的药物。
- 该评级为研究和按严重程度详细评估每种药物提供同质性。
适用人群与场景
- 成人重症患者( intensive care 场景)使用的药物评估。
诊断标准与关键阈值
- 肾毒性潜力指数评分标准:0=无肾毒性潜力,1=可能肾毒性潜力,2=很可能肾毒性潜力,3=确定肾毒性潜力。
研究设计与关键结果
- 研究类型:三轮、国际、跨学科、基于网络的改良德尔菲研究。
- 样本量:24名国际经验丰富临床医生,代表重症医学、肾脏病学和药学领域。
- 药物数量:从文献中识别159种药物,第一轮后新增8种,共167种药物。
- 主要结局:肾毒性评级达成共识;每轮评估评分以确定是否达成共识。
- 共识结果:肾毒性潜力指数评级显示20种药物为肾毒性很可能或很可能/确定。
证据类型、等级与局限
- 证据类型:改良德尔菲共识研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 肾毒性潜力指数评级可帮助机构肾毒性药物管理项目优先针对肾毒性潜力较高的药物。
- 该评级为研究和按严重程度详细评估每种药物提供同质性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The approach to evaluating nephrotoxins in studies of drug-associated acute kidney injury varies. Some studies use a list of under ten drugs for evaluation whereas others include over 100 drugs. Drugs are typically assigned a binary classification, nephrotoxic or not nephrotoxic. This oversimplifies the nephrotoxic potential of the drugs under investigation.
OBJECTIVE: This study aimed to assign a nephrotoxin potential for 167 drugs used in the adult critical care setting.
METHODS: A three-round, international, interdisciplinary, web-based modified-Delphi study was used to evaluate nephrotoxins used in adult critically ill patients. Twenty-four international experienced clinicians were identified through the Acute Disease Quality Initiative group and professional affiliations. Included individuals represented the fields of intensive care, nephrology, and pharmacy. One hundred and fifty-nine medications were identified from the literature, with eight additional medications added after the first round, for a total of 167 medications. The primary outcome was consensus achieved for nephrotoxicity ratings. Scores were evaluated each round to determine if a consensus was met.
RESULTS: Our nephrotoxin potential index rating indicated that 20 drugs were nephrotoxicity probable or probable/definite per consensus. Nephrotoxic potential was assessed based on the standard use of medications in intensive care and the following consensus scores: 0 = no nephrotoxic potential, 1 = possible nephrotoxic potential, 2 = probable nephrotoxic potential, 3 = definite nephrotoxic potential.
CONCLUSIONS: The nephrotoxin potential index rating allows for prioritization of targeted drugs with greater nephrotoxic potential for institutional nephrotoxin stewardship programs. Furthermore, the nephrotoxin potential index rating provides homogeneity for research and guidance on detailed assessments by severity for each drug.
参考来源
- Gray MP, Barreto EF, Schreier DJ, et al. Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method. Drug Saf. 2022. PMID: 35389144. doi:10.1007/s40264-022-01173-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。